Clinical research studies
We currently support a number of clinical research studies, including:
- CHERRY: Feasibility study on the effects of L-citrulline on cardiovascular function in hypertensive pregnant women. Women with hypertension identified before 16 weeks gestation will be invited to participate.
Contact: Heather Glossop /Catherine Chmiel ext. 16980/16968 - HOLDS: Nuliparous and over 16 years of age. 37-42 weeks gestation, singleton pregnancy. Confirmed delay in labour. Normal pregnancy.
Contact: Linda Peacock /Sam Ratcliffe ext. 16958/16980 - BOOST: Supplementation with cereal bars or tablets in young pregnant women. Aged <19 years at recruitment to the study. Singleton pregnancy.
Contact: Sam Ratcliffe ext. 16980 - MAViS: Women with Vascular Disease. >10 weeks gestation.
Contact: Catherine Chmiel and Heather Glossop ext. 16980/16968 - TEMPO: Pregancy with better eating and activity trial.
Contact: Christine Hughes ext. 11937 - BUMP: Blood Pressure Monitoring in Pregnancy to improve the detection and monitoring of hypertension. 16-24 weeks gestation with 1 risk factor for hypertension OR <37 weeks with existing hypertension.
Contact: Kim Farrant ext. 16958 - PAGE: Detecting problems in pregnancy, possibly requiring a CVS or Amniocentesis. Any gestation.
Contact: Sue Thornber ext. 16980 - IONA TWINS: Women undergoing CVS or Amniocentesis. Any gestation.
Contact: Linda Peacock ext. 16958 - GOT-IT: Women with Retained Placenta, >14 weeks gestation.
Contact: Linda Peacock ext. 16958 - C-STITCH: Preterm Birth Study. Women indicated for cervical cerclage: suture is randomised: monofilment vs braided.
Contact: Sue Thornber ext. 16980 - VELOCITY: Evaluation of fetal growth in pregnancies complicated by diabetes. Type 1 and 2 diabetes.
Contact: Heather Glossop ext. 16980 - INVEST: Mother presents with increased fetal movements to antenatal services (>28weeks).
Contact: Liz Ward/Kim Farrant ext. 16958 - TOMMYS: All pregnant women.
Contact: Jessica Morecroft /Christine Hughes ext. 16988 - RAINBOW: To explore the experiences and outcomes of women who attend the Rainbow clinic.
Contact: Louise Stephens/ Suzanne Thomas/ Christine Hughes ext. 11937 - PARROT: PlGF as a diagnostic test for pre-eclampsia. Women between 20-36+6 weeks gestation who have suspected pre-eclampsia, who require PE bloods.
Contact: Sarah Lee ext. 65022 - STOPPIT-2: Twin Pregnancies, 18+0 –20+6 gestation.
Contact: Sue Thornber ext. 16980 - PARENTS-2: Involving parents in the perinatal mortality meeting. Parents who have suffered a stillbirth or a neonatal death.
Contact: Kim Farrant ext. 16958 - FEMINA 3: Women attending 28 weeks onward with reduced fetal movement.
Contact: – Louise Stephens/Kim Farrant ext. 16965/16958 - PHOENIX: Pre-eclampsia, 34 – 36+6 weeks gestation.
Contact: Sarah Lee ext. 65022 - PEACOCK: Pre-eclampsia (34-36+6 weeks gestation) Can a Placental Growth Factor (PLGF) blood test (plus clinical factors), be used to help plan the management of women with pre-eclampsia in the future.
Contact: Sarah Lee ext. 65022 - PHOEBE: Pre-eclampsia (34-36+6 weeks gestation). Why women with PE might have changes in heart function postnatally.
Contact: Sarah Lee ext. 65022 - NUPS 2: New Ultrasound Parameters for predicting birth weight 2.
Contact: Sarah Lee or Dr Zoe Thurlwell ext. 65022
- REMIT-2: Women after 36 weeks gestation attending with reduced fetal movements.
Contact: Sam Ratcliffe/Linda Peacock ext. 16980/16958
